Related by context. All words. (Click for frequent words.) 81 Previously Treated 80 Improves Outcomes 80 Advanced Melanoma 80 Experimental Vaccine 79 Phase 2b Clinical Trial 79 Infected Patients 79 Pooled Analysis 78 Appears Safe 78 Survival Benefit 78 Hormone Receptor Positive 78 Postmenopausal Women 78 Chronic Hepatitis C 78 Drug Combo 78 Oral Fingolimod 78 Treatment Reduces 78 Prolongs Survival 78 Peginterferon 78 Newly Diagnosed Multiple Myeloma 78 Treatment Experienced 78 Improved Survival 78 Improves Survival 77 Advanced Prostate Cancer 77 Meets Primary Endpoint 77 Rheumatoid Arthritis Patients 77 Combination Treatment 77 Hormone Refractory Prostate Cancer 77 Ovarian Cancer Patients 77 Slow Progression 77 Naive Patients 77 Treated Patients 77 Elderly Patients 77 Patients Suffering 77 Antitumor Activity 77 Pediatric Patients 77 Drug Shows Promise 77 Complicated Skin 76 Unfractionated Heparin 76 Treatment Shows Promise 76 Long Term Efficacy 76 Adjuvant Chemotherapy 76 Sustained Efficacy 76 Shows Efficacy 76 Subgroup Analysis 76 Disease Progression 76 Knee Osteoarthritis 76 Advanced Colorectal Cancer 76 Bone Marrow Cells 76 HCV Protease Inhibitor 76 Inhaled Corticosteroids 76 HER2 Positive 76 Relapsing Multiple Sclerosis 76 Statin Therapy 76 Single Dose 76 Treatment Naïve 76 Relapsed Multiple Myeloma 76 Renal Cell Carcinoma 76 Vaccine Adjuvant 76 Sleep Disturbances 76 Adjuvant Treatment 76 Premenopausal Women 75 Breast Cancer Recurrence 75 Relapsed Refractory 75 Multiple Myeloma Patients 75 Shows Promise Against 75 Obesity Linked 75 Chronic Hepatitis B 75 Study Evaluating 75 Randomized Double Blind 75 Newly Diagnosed Patients 75 Resistant Hypertension 75 Peginterferon Alfa 2a 75 Investigational Agent 75 Demonstrates Efficacy 75 Osteoporosis Drug 75 Metastatic Prostate Cancer 75 FDA Approves Drug 75 Newly Diagnosed 75 See CLINICAL PHARMACOLOGY 75 Fewer Side Effects 75 Prostate Cancer Patients 75 Initiate Phase III 75 Lowering Blood Pressure 75 Previously Untreated 75 Investigational Drug 75 Improve Survival 75 HER2 Positive Breast Cancer 75 Vaccine Shows Promise 75 Critically Ill Patients 75 Phase 2b Trial 75 Node Positive 75 Breast Cancer Treatment 75 Dose Escalation 75 Kidney Transplant Patients 75 Study Shows Promise 75 Myeloma Patients 75 Phase IIb Trial 75 Castration Resistant Prostate Cancer 75 Chemotherapy Improves 75 Bone Metastases 74 Blood Pressure Drug 74 Patients Receiving 74 Protease Inhibitor 74 Viral Load 74 Phase 2a Trial 74 Rotavirus Vaccine 74 Inflammatory Markers 74 Patients Treated 74 Investigational Treatment 74 Combo Therapy 74 Anti Tumor Activity 74 Lung Cancer Patients 74 Heart Failure Patients 74 Advanced Ovarian Cancer 74 Demonstrates Potent 74 Gene Variant 74 Metastatic Colorectal Cancer 74 Pivotal Phase 74 Patients Treated With 74 Stomach Cancer 74 Epilepsy Drug 74 Severe Sepsis 74 Artery Disease 74 FDA Okays 74 Lowers Risk 74 Demonstrates Positive 74 Is Well Tolerated 74 alfa 2a 74 Adjuvant Therapy 74 Demonstrated Significant 74 Proves Effective 74 Inhaled Nitric Oxide 74 Randomized Clinical Trials 74 Increased Mortality 74 Enlarged Prostate 74 Carboplatin Paclitaxel 73 Inhaled Steroids 73 Glycemic Control 73 Therapy Improves 73 Adjunctive Therapy 73 Brain Tumor Patients 73 Shingles Vaccine 73 Showed Significant 73 Phase 2b Study 73 Osteoporosis Drugs 73 Gene Linked 73 Refractory Hodgkin Lymphoma 73 Shows Promising 73 Colorectal Adenomas 73 Genes Predict 73 Colorectal Cancer Patients 73 Hepatitis C Genotype 73 Drug Prevents 73 Estrogen Therapy 73 Potentially Fatal 73 Randomized Phase II 73 Anticancer Activity 73 Chronic Myeloid Leukemia 73 Hypertensive Patients 73 Statistically Significant 73 Follicular Lymphoma 73 Clinical Trial Results 73 Renal Impairment 73 Combination Therapy 73 Tumor Growth 73 Versus Placebo 73 Successfully Treated 73 Slows Progression 73 Drug Resistant 73 Study Showed 73 Myelodysplastic Syndromes 73 Severe Asthma 73 Premature Infants 73 Osteoarthritis Patients 73 Insulin Glargine 73 Trial Evaluating 73 Fibromyalgia Pain 73 Blood Pressure Drugs 73 Cutaneous T 73 Monotherapy 73 Vaccine Candidate 73 Venous Thromboembolism 73 Treating Chronic 73 Juvenile Idiopathic Arthritis 73 Blood Clot Risk 73 Metastatic Melanoma 73 Cardiovascular Events 73 Serious Infections 73 Partial Onset Seizures 73 Therapy Shows Promise 73 Completes Patient Enrollment 73 Lung Cancer Survival 73 Lupus Drug 73 Peginterferon Alfa 2b 73 Poorly Controlled 73 Prostate Cancer Vaccine 73 Mylan Receives Approval 73 Investigational Compound 73 Genes Linked 73 CDC Recommends 72 Commonly Used 72 Protein Linked 72 Drug Resistant TB 72 Aggressive Prostate Cancer 72 Preterm Labor 72 Demonstrates Sustained 72 Carotid Stenting 72 Vaccine Protects Against 72 Brain Atrophy 72 Left Ventricular Hypertrophy 72 Cocaine Addiction 72 Prostate Biopsy 72 Patients Undergoing 72 Gout Drug 72 Mouse Model 72 Well Tolerated 72 Chronic Cough 72 Anti Clotting Drug 72 Cognitive Impairment 72 Meta Analysis 72 Antiviral Drugs 72 Significantly Reduced 72 Boosts Survival 72 Erectile Dysfunction Drug 72 Polymerase Inhibitor 72 Randomized Phase 72 Antipsychotic Drug 72 Treat Heart Failure 72 Pneumococcal Vaccine 72 Gene Mutation 72 Hepatitis C Patients 72 First Patient Dosed 72 Relapsing Remitting Multiple Sclerosis 72 Bone Fractures 72 Diabetic Patients 72 Drug Coated Stents 72 Cardiac Resynchronization 72 Breast Cancer Patients 72 Hospital Acquired Pneumonia 72 Treatment Naive 72 Antipsychotic Drugs 72 Virus Linked 72 Stem Cell Treatment 72 Statin Drugs 72 Smoking Linked 72 Clostridium difficile Infection 72 Reduces Pain 72 Mg Usa 72 Anti Tumor 72 Fracture Risk 72 Reduce Mortality 72 Soft Tissue Sarcoma 72 MRSA Infections 72 Radical Prostatectomy 72 Gum Disease 72 Clinical Trial Evaluating 72 ST Elevation Myocardial 72 Autologous Stem Cell Transplantation 72 Heartburn Drugs 72 Clostridium Difficile Associated 72 Recurrent Breast Cancer 72 Therapeutic Efficacy 72 Oral Calcitonin 72 Invasive Breast Cancer 72 Prolongs Life 72 Often Misdiagnosed 72 Anti Nausea 72 Patient Enrollment 72 Antidepressants Linked 72 Oral Cladribine 72 Improve Outcomes 72 Plus Ribavirin 72 Hemodialysis Patients 72 Metastatic Renal Cell Carcinoma 72 Treatment Naive HIV 72 Less Invasive 72 Vaccine Prevents 72 Cancer Recurrence 72 Male Contraceptive 72 Long Term Survival 72 First Patient Enrolled 72 Active Rheumatoid Arthritis 72 Predict Risk 72 Human Monoclonal Antibody 72 Increased Risk 72 Breast Tumors 72 Significantly Improved 71 Cholesterol Lowering Drug 71 Combination REOLYSIN R 71 Menopausal Women 71 Fungal Infections 71 Aspirin Reduces 71 Brain Lesions 71 Bloodstream Infections 71 Muscle Function 71 Pneumonia Vaccine 71 Postmenopausal Osteoporosis 71 Depressive Symptoms 71 Pegylated Interferon 71 Randomized Controlled 71 Hepatitis C Treatment 71 Osteoporosis Treatment 71 Desvenlafaxine Succinate 71 Invasive Fungal Infections 71 Valvular Heart Disease 71 Phase 1b Clinical Trial 71 Chronic Sinusitis 71 Kidney Transplant Recipients 71 Randomized Trials 71 Novel Oral 71 Inflammatory Arthritis 71 Vaginal Gel 71 Moderate Drinking 71 Disease Modifying 71 Unresectable 71 Increases Risk 71 Hematological Cancers 71 Gene Mutations 71 Phase 2a Clinical Trial 71 Immune Responses 71 Lupus Nephritis 71 Skin Lesions 71 Phase III Clinical Trial 71 Pulmonary Arterial Hypertension 71 Antiviral Activity 71 Newly Diagnosed Breast Cancer 71 Expanded Indication 71 Helps Smokers Quit 71 Bipolar Mania 71 Genes Associated 71 Anemia Drug 71 Phase III Trial 71 Data Suggest 71 Vitamin D Linked 71 Pregnancy Linked 71 Antidepressant Use 71 Overactive Bladder 71 Hepatitis C Virus 71 Drug Candidate 71 Plaque Psoriasis 71 ORLive Presents 71 Cholesterol Drug 71 Preclinical Data 71 Dose Ranging 71 Schizophrenia Drug 71 Fixed Dose 71 Localized Prostate Cancer 71 Drug Resistant Staph 71 Treatment Regimen 71 Tiotropium 71 Phase III Trials 71 Viral Suppression 71 Hepatitis C Infection 71 Sustained Reduction 71 Effectively Treats 71 Liver Metastases 71 Obese Teens 71 Reduces Mortality 71 Demonstrate Significant 71 Transplant Patients 71 Ischemic Stroke 71 Reduces Risk 71 Lung Cancer Trial 71 Prove Effective 71 Immune Cells 71 Novel Mechanism 71 Malignant Glioma 71 Tipranavir 71 ACE Inhibitors 71 Demonstrates Significant 71 Blood Clots 71 Shown Effective 71 Calcium Supplements 71 Cholesterol Levels 71 Lymph Nodes 71 Prospective Randomized 71 Predict Prostate Cancer 71 Chronic Inflammation 71 Brain Scans 71 Test Detects 71 Arthritis Drug 71 Phase IIb Clinical Trial 71 Hip Fractures 71 Vildagliptin 71 Clinically Significant 71 Mg Uk 71 Paclitaxel Carboplatin 71 Breathing Problems 71 Anticancer Drugs 71 Malignant Melanoma 71 Eases Pain 71 II Clinical Trial 71 Breast Cancers 71 Interferon Beta 71 Asthma Symptoms 71 Kidney Function 71 Drug Combinations 71 Preterm Delivery 71 Calcium Vitamin D 71 Reduced Risk 71 Hormone Therapy 71 Completes Enrollment 71 Perifosine KRX 71 Gene Variation 71 Cholesterol Drugs 71 Visceral Fat 71 Arthritis Sufferers 71 Hsp# Inhibitor 70 Cognitive Function 70 Anthracycline 70 Treatment Resistant 70 Lung Cancer Drug 70 Blood Thinner 70 Cardiovascular Outcomes 70 Blood Cancers 70 Liver Failure 70 Pharmacokinetic Study 70 Sinus Infections 70 Inflammatory Disease 70 Primary Hypercholesterolemia 70 Pre Cancerous 70 Asthma Attacks 70 Placebo Controlled Study 70 Renal Function 70 Seasonal Allergies 70 Stem Cell Transplants 70 Vasomotor Symptoms 70 Bipolar Depression 70 Asthma Treatment 70 FDA Approves Novel 70 Integrase Inhibitor 70 Prophylactic Treatment 70 Teva Provides Update 70 Prostate Surgery 70 Colorectal Cancer Risk 70 Capsules CII 70 Prevent Stroke 70 Gene Mutation Linked 70 Secondary Hyperparathyroidism 70 Peanut Allergy 70 Oral Laquinimod 70 Obese Patients 70 Colorectal Cancers 70 Therapy Reduces 70 Chemoradiation 70 Anticoagulant 70 Pharmacyclics Announces 70 Healthbeat Report 70 Drug Regimen 70 Albuferon TM 70 Androgen Deprivation Therapy 70 Brentuximab Vedotin SGN 70 Bone Marrow Transplants 70 Seasonal Influenza Vaccine 70 Premature Births 70 Unstable Angina 70 Levels Linked 70 Epoetin Alfa 70 Double Blind Placebo 70 Nicotine Vaccine 70 Novel Antibiotic 70 JAK2 Inhibitor 70 Tuberculosis Vaccine 70 FDA Approvals 70 Acute Pancreatitis 70 Migraine Headaches 70 Topline Results 70 Autoimmune Disease 70 Ample Supply 70 Bone Fracture 70 Genetic Variation 70 Pivotal Phase III 70 Non Inferiority 70 Genetic Variations 70 Chronic Stress 70 Atopic Dermatitis 70 Symptom Relief 70 Anti Inflammatory Drug 70 Rectal Cancer 70 Kidney Transplants 70 Epilepsy Drugs 70 Virus Infection 70 Bacterial Infections 70 Kidney Failure 70 CYP#A# substrate 70 Pharmacokinetics PK 70 Second Pivotal Phase 70 Preclinical Models 70 Potentially Deadly 70 Vitamin D Levels 70 Chronic HCV 70 Adefovir 70 Hospitalization Rates 70 Chronic Lung 70 Cell Transplants 70 Bosutinib 70 Diabetic Foot Ulcer 70 NICE Recommends 70 HCV Genotype 70 Treating Depression 70 Tyrosine Kinase Inhibitor 70 Lung Injury 70 Dementia Patients 70 Rare Genetic 70 Cognitive Deficits 70 Initiate Phase 70 Zsa Zsa Gabor Hospitalized 70 Glatiramer Acetate 70 Physical Function 70 Predict Breast Cancer 70 Gene Variants 70 Intravenous Formulation 70 Testosterone Therapy 70 Risedronate 70 Sipuleucel T 70 Smallpox Vaccine 70 Liver Damage 70 Insulin Resistance 70 Neoadjuvant Chemotherapy 70 Anal Cancer 70 Guidelines Recommend 70 Acute Heart Failure 70 Severe Acne 70 Recurrent Glioblastoma 70 Study Evaluates 70 Strongly Linked 69 Prostate Cancer Survival 69 See CONTRAINDICATIONS 69 Treating Heart Failure 69 Viral Infections 69 Uterine Fibroid Embolization 69 Clinical Efficacy 69 Improve Patient Outcomes 69 Significant Reduction 69 Bronchopulmonary Dysplasia 69 FDA Panel Recommends 69 Excessive Sweating 69 Thyroid Cancer 69 Acute Migraine 69 Controlled Study 69 Respiratory Virus 69 Prognostic Factors 69 Stem Cell Transplant 69 adalimumab Humira 69 Inhaled Insulin 69 Testosterone Levels 69 Migraine Treatment 69 Proven Effective 69 Morbidity Mortality 69 Clot Risk 69 Valopicitabine 69 Lowers Blood Pressure 69 Skeletal Muscle 69 Initiate Clinical Trial 69 Diabetic Neuropathic Pain 69 Dengue Virus 69 ER Visits 69 Relapsed Refractory Aggressive 69 ST Segment Elevation 69 Bare Metal Stents 69 Confirmatory Phase 69 Placebo Controlled Trial 69 Survival Rates 69 Orthostatic Hypotension 69 Ebola Vaccine 69 Dementia Risk 69 Helps Relieve 69 Abiraterone Acetate 69 Peanut Allergies 69 Successfully Completes Phase 69 Generic Versions 69 Elevated Levels 69 Double Blind Randomized 69 Acute Ischemic Stroke 69 Septic Shock 69 Urinary Incontinence 69 Lung Function 69 Migraine Headache 69 Transplant Patient 69 Treat Anemia 69 Lower Blood Pressure 69 Postherpetic Neuralgia 69 Genital Herpes 69 Gastric Cancer 69 Immunomedics Announces 69 Preclinical Study 69 JAK Inhibitor 69 FDA Accepts 69 Acute Coronary Syndromes 69 Prostate Tumors 69 Pregnant Smokers 69 Telaprevir VX 69 Colon Polyps 69 Liver Toxicity 69 Blocked Arteries 69 Renal Anemia 69 Acne Drug 69 Advanced Solid Tumors 69 Genetic Variants 69 Study Demonstrates 69 Antipsychotic Medications 69 Treatment Naïve Patients 69 Regimens 69 Guidelines Issued 69 Placebo Controlled 69 Prostate Cancer Treatment 69 Nebulized 69 Osteoarthritis Pain 69 Esophageal Cancer 69 Non Responders 69 Zoledronic Acid 69 Transplant Recipient 69 Anti Angiogenesis 69 Brain Tumors 69 Whooping Cough Vaccine 69 Beta Blocker 69 Atypical Hemolytic Uremic Syndrome 69 Acute Exacerbations 69 Dose Ranging Study 69 Drug Fails 69 Knee Arthritis 69 Mouse Models 69 Systemic Sclerosis 69 Respiratory Distress 69 CYP#A# CYP#D# 69 FDA Approves Generic 69 Bevacizumab 69 Organ Rejection 69 Advanced Renal Cell 69 Unstable Angina Non 69 Thyroid Hormone 69 Insulin Sensitivity 69 Diabetic Nephropathy 69 Panic Disorder 69 Non Invasive Treatment 69 Receives Orphan Drug Designation 69 Lung Cancer Risk 69 Allergic Rhinitis 69 Initiates Clinical Trial 69 Stable Coronary Artery 69 Help Predict 69 Migraine Sufferers 69 Long Term Outcomes 69 Dose Finding 69 Progressive Multifocal Leukoencephalopathy 69 Phase III Pivotal 69 Combination Vaccine 69 Rheumatoid Arthritis Drug 69 Migraine Pain 69 Ovary Removal 69 Viral Infection 69 Brain Metastases 69 Gastric Ulcers 69 Allergic Reactions 69 pralatrexate injection folate analogue 69 Low Dose 69 Novel Treatments 69 Submits NDA 69 Gout Patients 69 Hypercholesterolemia 69 Antibiotic Resistant 69 Premature Babies 69 Genetic Variant 69 Antiretroviral Agents 69 Randomized Double blind 69 Predict Response 69 Heterozygous Familial Hypercholesterolemia 69 Leukemias 69 Hepatitis B Vaccine 69 Breast Cancer Cells 69 Glufosfamide 69 Oral Anticoagulant 69 Hepatocellular Carcinoma 69 Vicriviroc 69 Hepatic Encephalopathy 69 Asthma Medication 69 Clinical Outcomes 69 Watchful Waiting 69 Amgen Neulasta R 69 Chronic Constipation 69 Community Acquired Pneumonia 69 Novel Compounds 69 Minimally Invasive Treatment 69 Hyperlipidemia 69 Treating Prostate Cancer 68 Cervical Cancer Vaccine 68 Genes Identified 68 Leukemia Cells 68 Low Incidence 68 Severely Obese 68 RNAi Therapeutic 68 Initiates Enrollment 68 R Bortezomib 68 Commonly Prescribed 68 Pain Medications 68 Antibiotic Use 68 Effective Than 68 Beta Blockers 68 Significantly Reduces 68 Clot Busting 68 Earns Milestone Payment 68 Seasonal Allergic Rhinitis 68 FUSILEV enhances 68 Stem Cell Procedure 68 Statistical Significance 68 IIa Clinical Trial 68 Bleeding Disorder 68 Potent Antiviral Activity 68 Capecitabine 68 Initiates Phase III 68 Topical Treatment 68 Clinical Outcome 68 Genetic Mutation 68 Irregular Heartbeat 68 Nymox NX 68 Hepatitis B Virus 68 Vaccine Trials 68 Maven Semantic 68 Multicenter Trial 68 Bladder Cancer 68 R lenalidomide 68 IND Filing 68 Higher Doses 68 Cholesterol Lowering 68 Accurate Diagnosis 68 ritonavir boosted 68 Genetic Mutations 68 Hospitalized Patients 68 Trial Halted 68 Lymphoma Patients 68 Adenoma 68 Medication Adherence 68 Therapeutic Vaccines 68 PRN FDA Approves 68 Respiratory Infections 68 Renal Cancer 68 Cardiovascular Disease Risk 68 Bivalirudin 68 Pancreatic Adenocarcinoma 68 Hormone Replacement 68 Medication Compliance 68 Adalimumab 68 Cholesterol Lowering Drugs 68 Brain Shrinkage 68 EntreMed Presents 68 Respiratory Syncytial Virus 68 Bronchodilator 68 Novel Therapeutic 68 Sangamo BioSciences Announces 68 Early Diagnosis 68 Orally Active 68 Study Reinforces 68 Controlled Trial 68 Recurrent Ovarian Cancer 68 Causes Symptoms 68 Beneficial Effects 68 Physician Insights 68 Multiple Sclerosis Rheumatoid Arthritis 68 Advanced Pancreatic Cancer 68 Investigational Oral 68 Sapacitabine 68 Vitrasert R 68 Limb Ischemia 68 Efficacious 68 Drug Resistant Bacteria 68 Fluorouracil 68 Humanized Anti 68 Pivotal Study 68 Birth Defect Risk 68 Gastric Bypass Surgery 68 Abortion Pill 68 Randomized Controlled Trials 68 Antiretroviral Therapy 68 Cancer Incidence Mortality 68 Vigorous Exercise 68 COPEGUS R 68 Therapeutic Vaccine 68 Neovascular Age Related Macular 68 Breast Tumor 68 Fulvestrant 68 Hedgehog Pathway 68 Childhood Immunizations 68 Lung Transplants 68 Novel Compound 68 Mosquito Bites 68 Ovarian Cancers 68 Dialysis Patients 68 Therapeutic Antibody 68 Atypical Antipsychotics 68 Protein Involved 68 Endothelial Function 68 Psoriasis Drug 68 AVI BioPharma Announces 68 Muscle Wasting 68 Efficacy Trial 68 Brain Aneurysms 68 Biogen Genentech 68 Ear Infections 68 Interferon beta 1a 68 Lipid Lowering 68 Laryngeal Cancer 68 Aspirin Therapy 68 Genetic Predisposition 68 First Patient Treated 68 Prostate Cancer Surgery 68 Breast Density 68 Arterial Disease 68 Gene Therapy Trial 68 TNF Blockers 68 Pulmonary Artery 68 Benign Prostatic Hyperplasia 68 Rotavirus Vaccines 68 Chronic Heart Failure 68 Survival Rate 68 Cervical Dysplasia 68 Antiviral Drug 68 ADHD Medication 68 Protease Inhibitors 68 NDA Submission 68 FDA Clears 68 #:#-#,# CrossRef Medline [002] 68 Generalized Anxiety Disorder 68 Postmenopausal 68 Urinary Tract Infections 68 Antiplatelet Therapy 68 Pandemic Influenza Vaccine 68 Dendritic Cells 68 Phospholipase A2 68 Novel Method 68 Abdominal Pain 68 STELARA TM 68 Prognostic Significance 68 Chemotherapy Regimen 68 Urine Test 68 Prevent Fractures 68 Blood Thinning 68 Presents Positive 68 Cognitive Decline 68 Randomized Phase III 68 Blood Pressure Medication 68 Multidrug Resistant 68 Blood Pressure Lowering 68 Childhood Leukemia 68 Opioid Use 68 Lung Tumors 68 Gestational Diabetes 68 COPD Exacerbations 68 Pivotal Clinical Trial 68 Being Studied 68 Doctors Warn 68 Aurora Kinase 68 Helps Predict 68 Patients Enrolled 67 Post Menopausal 67 Crit Rev 67 Breast Cancer Metastasis 67 Pain Relievers 67 Transdermal Patch 67 Immune Cell 67 MEK Inhibitor 67 Hepatotoxicity 67 Blood Transfusions 67 Psoriasis Patients 67 Factor Receptor 67 REYATAZ ® 67 Antibody Drug Conjugate 67 Medication Errors 67 Granted Orphan Drug 67 Circulating Tumor Cells 67 Severe Psoriasis 67 Skin Cancers 67 Thrombotic 67 Sandostatin R 67 Exercise Reduces 67 Stent Implantation 67 Iron Deficiency 67 Immunosuppression 67 Cancer Cells 67 relapsed MM 67 J Allergy Clin 67 #-# Full Text 67 Diabetic Kidney Disease 67 Chronic Lymphocytic Leukemia 67 Genital Warts 67 Boceprevir 67 Phase III Pivotal Trial 67 Endometrial Cancer 67 Improve Diagnosis 67 Prenatal Exposure 67 Testosterone Patch 67 Receives Positive Opinion 67 Fat Cells 67 Files IND 67 Back Pain Sufferers 67 Could Predict 67 Initiates Phase 67 Study Casts Doubt 67 Thromboembolism 67 Prevent Breast Cancer 67 Rheumatoid 67 Significantly Improves 67 Rat Poison Found 67 Fast Track Status 67 Patient Outcomes 67 Ovarian Cancer Risk 67 Antitumor 67 patients coinfected 67 Improve Patient Safety 67 Tolerability 67 Relapsed Refractory Multiple Myeloma 67 Oral Formulation 67 Aliskiren 67 Antipsychotic 67 Sleep Duration 67 Etanercept 67 Hepatitis C Virus Infection 67 Bacterial Infection 67 Lung Cancers 67 Lung Infection 67 myocardial infarction ventricular fibrillation 67 Childhood Trauma 67 Fondaparinux 67 Cases Linked 67 Pivotal Trials 67 Pregnancy Complications 67 Significant Improvement 67 Antibiotic Treatment 67 Colorectal Screening 67 Antiplatelet 67 Premature Birth 67 Suffer Depression 67 Genetic Defect 67 Universal Flu Vaccine 67 Detect Cancer 67 Progenitor Cells 67 ISTA Pharmaceuticals Announces 67 Subtypes 67 Osteoarthritis Knee Pain 67 Significant Improvements 67 Asthma Allergies 67 Susceptibility Gene 67 Comorbidities 67 Myelofibrosis 67 Renal Cell Cancer 67 Pegylated Liposomal Doxorubicin 67 Endothelial Cells 67 Generic Version 67 Heart Defects 67 Mesothelioma Treatment 67 Vitamin D Deficiency 67 Help Smokers Quit 67 Cinacalcet 67 Nasal Powder 67 Painkiller Abuse 67 Presents Preclinical Data 67 NPS Pharmaceuticals Announces 67 Late Breaker 67 Systematic Review 67 Liver Injury 67 evaluating picoplatin 67 Staph Infections 67 Anticancer Drug 67 Nilotinib 67 IMiDs ® 67 Epratuzumab 67 Biologic Therapy 67 moderate renal impairment 67 inflammatory PDE 67 infliximab monotherapy 67 Launches Generic Version 67 refractory chronic lymphocytic 67 Non Alcoholic Fatty 67 Relieves Pain 67 Tumor Cells 67 Dietary Fat 67 Suicidality 67 J Am Coll 67 Lifting Weights 67 investigational oral inhibitor 67 Corticosteroid 67 Platinol ® 67 Cerebrospinal Fluid 67 Stent Placement 67 Crofelemer budesonide foam 67 Cardiovascular Mortality 67 Prostate Cancer Risk 67 Recombinant Human 67 Pediatric Asthma 67 Adjunctive Treatment 67 Complete Remission 67 Autologous Stem Cell 67 Coronary Arteries 67 Rigel R# 67 Synta Announces 67 Diabetic Foot Ulcers 67 Metastatic Pancreatic Cancer 67 humanized interleukin 6 67 Achieves Primary Endpoint 67 Targeted Therapy 67 Cancer Patients Treated